IBDEI0KN ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27912,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,27912,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,27913,0)
 ;;=742.3^^155^1748^53
 ;;^UTILITY(U,$J,358.3,27913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27913,1,3,0)
 ;;=3^Hydrocephalus,Congenital
 ;;^UTILITY(U,$J,358.3,27913,1,4,0)
 ;;=4^742.3
 ;;^UTILITY(U,$J,358.3,27913,2)
 ;;=^59563
 ;;^UTILITY(U,$J,358.3,27914,0)
 ;;=743.57^^155^1748^85
 ;;^UTILITY(U,$J,358.3,27914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27914,1,3,0)
 ;;=3^Optic Disc Coloboma,Congenital
 ;;^UTILITY(U,$J,358.3,27914,1,4,0)
 ;;=4^743.57
 ;;^UTILITY(U,$J,358.3,27914,2)
 ;;=^272837
 ;;^UTILITY(U,$J,358.3,27915,0)
 ;;=747.81^^155^1748^2
 ;;^UTILITY(U,$J,358.3,27915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27915,1,3,0)
 ;;=3^AVM,Brain,Congenital
 ;;^UTILITY(U,$J,358.3,27915,1,4,0)
 ;;=4^747.81
 ;;^UTILITY(U,$J,358.3,27915,2)
 ;;=^272916
 ;;^UTILITY(U,$J,358.3,27916,0)
 ;;=780.1^^155^1748^44
 ;;^UTILITY(U,$J,358.3,27916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27916,1,3,0)
 ;;=3^Hallucinations,Auditory
 ;;^UTILITY(U,$J,358.3,27916,1,4,0)
 ;;=4^780.1
 ;;^UTILITY(U,$J,358.3,27916,2)
 ;;=^53738
 ;;^UTILITY(U,$J,358.3,27917,0)
 ;;=780.2^^155^1748^112
 ;;^UTILITY(U,$J,358.3,27917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27917,1,3,0)
 ;;=3^Syncope
 ;;^UTILITY(U,$J,358.3,27917,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,27917,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,27918,0)
 ;;=780.39^^155^1748^110
 ;;^UTILITY(U,$J,358.3,27918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27918,1,3,0)
 ;;=3^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,27918,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,27918,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,27919,0)
 ;;=780.4^^155^1748^32
 ;;^UTILITY(U,$J,358.3,27919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27919,1,3,0)
 ;;=3^Dizziness
 ;;^UTILITY(U,$J,358.3,27919,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,27919,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,27920,0)
 ;;=780.71^^155^1748^22
 ;;^UTILITY(U,$J,358.3,27920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27920,1,3,0)
 ;;=3^Chronic Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,27920,1,4,0)
 ;;=4^780.71
 ;;^UTILITY(U,$J,358.3,27920,2)
 ;;=^304659
 ;;^UTILITY(U,$J,358.3,27921,0)
 ;;=795.79^^155^1748^1
 ;;^UTILITY(U,$J,358.3,27921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27921,1,3,0)
 ;;=3^ACLA/APLA
 ;;^UTILITY(U,$J,358.3,27921,1,4,0)
 ;;=4^795.79
 ;;^UTILITY(U,$J,358.3,27921,2)
 ;;=^303352
 ;;^UTILITY(U,$J,358.3,27922,0)
 ;;=854.01^^155^1748^120
 ;;^UTILITY(U,$J,358.3,27922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27922,1,3,0)
 ;;=3^TBI-Open Wound,No LOC
 ;;^UTILITY(U,$J,358.3,27922,1,4,0)
 ;;=4^854.01
 ;;^UTILITY(U,$J,358.3,27922,2)
 ;;=^274712
 ;;^UTILITY(U,$J,358.3,27923,0)
 ;;=854.02^^155^1748^118
 ;;^UTILITY(U,$J,358.3,27923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27923,1,3,0)
 ;;=3^TBI-Open Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,27923,1,4,0)
 ;;=4^854.02
 ;;^UTILITY(U,$J,358.3,27923,2)
 ;;=^274713
 ;;^UTILITY(U,$J,358.3,27924,0)
 ;;=854.03^^155^1748^117
 ;;^UTILITY(U,$J,358.3,27924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27924,1,3,0)
 ;;=3^TBI-Open Wound,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,27924,1,4,0)
 ;;=4^854.03
 ;;^UTILITY(U,$J,358.3,27924,2)
 ;;=^274714
 ;;^UTILITY(U,$J,358.3,27925,0)
 ;;=854.04^^155^1748^119
 ;;^UTILITY(U,$J,358.3,27925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27925,1,3,0)
 ;;=3^TBI-Open Wound,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,27925,1,4,0)
 ;;=4^854.04
 ;;^UTILITY(U,$J,358.3,27925,2)
 ;;=^274715
 ;;^UTILITY(U,$J,358.3,27926,0)
 ;;=854.11^^155^1748^114
 ;;^UTILITY(U,$J,358.3,27926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27926,1,3,0)
 ;;=3^TBI-Closed Wound,No LOC
 ;;^UTILITY(U,$J,358.3,27926,1,4,0)
 ;;=4^854.11
 ;;^UTILITY(U,$J,358.3,27926,2)
 ;;=^274721
 ;;^UTILITY(U,$J,358.3,27927,0)
 ;;=854.12^^155^1748^113
 ;;^UTILITY(U,$J,358.3,27927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27927,1,3,0)
 ;;=3^TBI-Closed Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,27927,1,4,0)
 ;;=4^854.12
 ;;^UTILITY(U,$J,358.3,27927,2)
 ;;=^274722
 ;;^UTILITY(U,$J,358.3,27928,0)
 ;;=854.13^^155^1748^115
 ;;^UTILITY(U,$J,358.3,27928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27928,1,3,0)
 ;;=3^TBI-Closed,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,27928,1,4,0)
 ;;=4^854.13
 ;;^UTILITY(U,$J,358.3,27928,2)
 ;;=^274723
 ;;^UTILITY(U,$J,358.3,27929,0)
 ;;=854.14^^155^1748^116
 ;;^UTILITY(U,$J,358.3,27929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27929,1,3,0)
 ;;=3^TBI-Closed,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,27929,1,4,0)
 ;;=4^854.14
 ;;^UTILITY(U,$J,358.3,27929,2)
 ;;=^274724
 ;;^UTILITY(U,$J,358.3,27930,0)
 ;;=908.3^^155^1748^17
 ;;^UTILITY(U,$J,358.3,27930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27930,1,3,0)
 ;;=3^Carotid Cavernous Fistula,Late Effect
 ;;^UTILITY(U,$J,358.3,27930,1,4,0)
 ;;=4^908.3
 ;;^UTILITY(U,$J,358.3,27930,2)
 ;;=^275249
 ;;^UTILITY(U,$J,358.3,27931,0)
 ;;=368.2^^155^1749^24
 ;;^UTILITY(U,$J,358.3,27931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27931,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,27931,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,27931,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,27932,0)
 ;;=695.3^^155^1749^2
 ;;^UTILITY(U,$J,358.3,27932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27932,1,3,0)
 ;;=3^Acne Rosacea
 ;;^UTILITY(U,$J,358.3,27932,1,4,0)
 ;;=4^695.3
 ;;^UTILITY(U,$J,358.3,27932,2)
 ;;=Acne Rosacea^107114
 ;;^UTILITY(U,$J,358.3,27933,0)
 ;;=250.00^^155^1749^22
 ;;^UTILITY(U,$J,358.3,27933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27933,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,27933,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,27933,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,27934,0)
 ;;=346.90^^155^1749^41
 ;;^UTILITY(U,$J,358.3,27934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27934,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,27934,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,27934,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,27935,0)
 ;;=376.30^^155^1749^30
 ;;^UTILITY(U,$J,358.3,27935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27935,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,27935,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,27935,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,27936,0)
 ;;=368.8^^155^1749^7
 ;;^UTILITY(U,$J,358.3,27936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27936,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,27936,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,27936,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,27937,0)
 ;;=362.34^^155^1749^5
 ;;^UTILITY(U,$J,358.3,27937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27937,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,27937,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,27937,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,27938,0)
 ;;=368.13^^155^1749^88
 ;;^UTILITY(U,$J,358.3,27938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27938,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,27938,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,27938,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,27939,0)
 ;;=368.40^^155^1749^113
 ;;^UTILITY(U,$J,358.3,27939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27939,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,27939,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,27939,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,27940,0)
 ;;=369.4^^155^1749^58
 ;;^UTILITY(U,$J,358.3,27940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27940,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,27940,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,27940,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,27941,0)
 ;;=250.01^^155^1749^21
 ;;^UTILITY(U,$J,358.3,27941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27941,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,27941,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,27941,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,27942,0)
 ;;=V08.^^155^1749^40
 ;;^UTILITY(U,$J,358.3,27942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27942,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,27942,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,27942,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,27943,0)
 ;;=921.0^^155^1749^16
 ;;^UTILITY(U,$J,358.3,27943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27943,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,27943,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,27943,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,27944,0)
 ;;=379.91^^155^1749^87
 ;;^UTILITY(U,$J,358.3,27944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27944,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,27944,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,27944,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,27945,0)
 ;;=V58.69^^155^1749^44
 ;;^UTILITY(U,$J,358.3,27945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27945,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,27945,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,27945,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,27946,0)
 ;;=871.4^^155^1749^54
 ;;^UTILITY(U,$J,358.3,27946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27946,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,27946,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,27946,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,27947,0)
 ;;=242.90^^155^1749^108
 ;;^UTILITY(U,$J,358.3,27947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27947,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,27947,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,27947,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,27948,0)
 ;;=135.^^155^1749^101
 ;;^UTILITY(U,$J,358.3,27948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27948,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,27948,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,27948,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,27949,0)
 ;;=446.5^^155^1749^107
